People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cofactor Genomics, Inc. | — | Biotechnology | Series A | $18.8M | $9.8M | 2017 |
Matthew A. Ocko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew A. Ocko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Siegel | 1 | 8 |
| John Kuelper | 1 | 6 |
| Armen Vidian | 1 | 5 |
| William Hagstrom | 1 | 4 |
| Jon Armstrong | 1 | 2 |
| Jarret Glassock | 1 | 1 |
| David Messina | 1 | 1 |
| Jarret Glasscock | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.